Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 8:10:2903-11.
doi: 10.3762/bjoc.10.308. eCollection 2014.

Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery

Affiliations

Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery

Anxo Fernández-Ferreiro et al. Beilstein J Org Chem. .

Abstract

Fluconazole was studied with two different hydrophilic cyclodextrins (hydroxypropyl-β-cyclodextrin (HPBCD) and sulfobutyl ether-β-cyclodextrin (SBECD)) for the formation of inclusion complexes. HPBCD and SBECD showed low cell cytotoxicity in human keratocytes as assessed by the label-free xCELLigence system for real-time monitoring. The fluconazole-HPBCD complex was incorporated into an ion-sensitive ophthalmic gel composed of the natural polysaccharides gellan gum and κ-carrageenan. This system showed good bioadhesive properties and effective control of fluconazole release.

Keywords: cyclodextrins; eye drops; fluconazole; hydroxypropyl-β-cyclodextrin; sulfobutylether-β-cyclodextrin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Phase solubility diagrams for fluconazole obtained with β-cyclodextrin derivatives at 25 °C in water (mean ± SD, n = 6). The dotted lines indicate the necessary CD concentration required to solubilize 10 mg/mL of fluconazole.
Figure 2
Figure 2
Solubility of fluconazole in aqueous solutions containing 5% of CD and 0.5% of the respective polysaccharide.
Figure 3
Figure 3
Ocular cytotoxicity studies of HPBCD and SBECD in primary corneal human keratocytes, using real-time xCELLigence impedance analysis. (a) Kinetic curve survival rates for HPBCD; (b) Kinetic curve survival rates for SBECD; (c) Evolution of IC50 vs time for HPBCD and SBECD. IC50 values at each time were calculated using (a) and (b); IC50 represents the concentration that causes a reduction in the survival of 50% of the cells.
Figure 4
Figure 4
Ocular cytotoxicity studies of fluconazole in primary corneal human keratocytes obtained using real-time xCELLigence impedance analysis. (a) Kinetic curve survival rates; (b) evolution of IC50 vs time.
Figure 5
Figure 5
HET-CAM assay: (a) positive Control (NaOH 0.1 N); (b) negative control (NaCl 0.9%); (c) HPBCD 10 mg/mL; (d) SBECD 10 mg/mL; (e) fluconazole (2 mg/mL). Photographs show the status of the vessel at the end of the experiment.
Figure 6
Figure 6
Bioadhesive properties (bioadhesion work and maximum force of detachment) of ion-sensitive hydrogels using tanned leather as a substrate (mean ± SD, n = 6).
Figure 7
Figure 7
Release profiles of fluconazole in simulated tear fluid from the gels with (closed symbols) or without (open symbols) HPBCDs and different proportions of polysaccharides (mean ± SEM, n = 3).

References

    1. Miller D. Expert Opin Pharmacother. 2013;14:543–560. doi: 10.1517/14656566.2013.775248. - DOI - PubMed
    1. Keay L J, Gower E W, Iovieno A, Oechsler R A, Alfonso E C, Matoba A, Colby K, Tuli S S, Hammersmith K, Cavanagh D, et al. Ophthalmology. 2011;118:920–926. doi: 10.1016/j.ophtha.2010.09.011. - DOI - PMC - PubMed
    1. Mravii I, Dekaris I, Gabri N, Romac I, Glavota V, Mlinari E. In: Keratitis. Srinivasan M, editor. InTech; 2012.
    1. Kathiravan M K, Salake A B, Chothe A S, Dudhe P B, Watode R P, Mukta M S, Gadhwe S. Bioorg Med Chem. 2012;20:5678–5698. doi: 10.1016/j.bmc.2012.04.045. - DOI - PubMed
    1. Pfaller M A, Diekema D J, Sheehan D J. Clin Microbiol Rev. 2006;19:435–447. doi: 10.1128/CMR.19.2.435-447.2006. - DOI - PMC - PubMed

LinkOut - more resources